Kezar Life Sciences, Inc.
Biotechnology · Healthcare
CEO
2023-11-07–present
Christopher Kirk, Ph.D.
CEO
Kezar Life Sciences, Inc.
Equibles does not estimate personal net worth.
About Christopher Kirk, Ph.D.
Christopher Kirk, Ph.D. is recorded as CEO at Kezar Life Sciences, Inc. since November 7, 2023. Kezar Life Sciences, Inc. reported in an 8-K filed October 3, 2023 that Christopher Kirk, Ph.D. was appointed Chief Executive Officer, effective November 7, 2023. Kezar Life Sciences, Inc. reported in an 8-K filed February 28, 2023 that Christopher Kirk, Ph.D. resigned as President, Chief Scientific Officer, effective April 21, 2023. Kezar Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“Christopher Kirk, Ph.D., the Company's co-founder and member of the Board, has been appointed to serve as Chief Executive Officer, effective as of the Effective Date.”
“On February 27, 2023, Christopher Kirk, Ph.D., President, Chief Scientific Officer and member of the Board of Directors (the "Board") of Kezar Life Sciences, Inc. (the "Company"), provided notice of his intention to resign from the positions of President and Chief Scientific Officer of the Company for personal reasons, effective April 21, 2023 (the "Resignation Date").”
Affiliation history
-
Kezar Life Sciences, Inc.
CEO
SEC 8-K
Current2023-11-07–present